Cargando…
TNF-a Is a Potent Stimulator of Tc9-Cell Differentiation
Tumor-specific Tc9 cells exhibit an excellent antitumor potential in tumor immunotherapy. Identification of factors that contribute to Tc9-cell differentiation may have important clinical significance. In this study, we found that tumor necrosis factor (TNF)-α promotes Tc9 differentiation in vitro,...
Autores principales: | Yang, Siyu, Chen, Jintong, Zhang, Hong, Jiang, Yuxue, Qin, Tianxue, Gao, Sujun, Yue, Ying, Wang, Siqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664956/ https://www.ncbi.nlm.nih.gov/pubmed/32842039 http://dx.doi.org/10.1097/CJI.0000000000000335 |
Ejemplares similares
-
TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways
por: Jiang, Yuxue, et al.
Publicado: (2019) -
Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1
por: Zhu, Xiaoqing, et al.
Publicado: (2017) -
IL-24 is the key effector of Th9 cell-mediated tumor immunotherapy
por: Chen, Jintong, et al.
Publicado: (2023) -
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
por: Zhao, Yinghua, et al.
Publicado: (2016) -
Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells
por: Chen, Jintong, et al.
Publicado: (2018)